Related Experiment Videos
Assessing the input costs of disease management programs
1Center for Pharmaceutical Economics, University of Arizona, Tucson, USA.
Clinical Therapeutics
|November 1, 1996
Summary
This paper offers a practical guide for assessing disease intervention costs. It details essential information for setting cost targets and monitoring expenses in disease management programs.
Area of Science:
- Health economics
- Disease management
- Cost-effectiveness analysis
Background:
- Accurate cost evaluation is crucial for effective disease management programs.
- Retrospective therapy cost estimates and treatment pathway analyses inform future cost projections.
- Understanding cost impacts is vital for resource allocation in public health.
Framework:
- A structured framework for input cost analysis is presented.
- Key classifications for cost assessment in disease management are identified.
- This framework supports baseline cost identification and target setting.
Implementation:
- Outlines information requirements for disease intervention cost modeling.
- Details costing needs for diverse disease management interventions.
- Addresses principal obstacles encountered in cost assessment.
Implications:
- Enables robust monitoring of costs throughout program agreements.
- Facilitates informed decision-making in healthcare resource allocation.
- Provides a blueprint for evaluating the financial viability of health interventions.